Country

Clinical trials in Mexico

Active obesity and GLP-1 studies with at least one location in Mexico.

46active studies

16recruiting now

39countries represented

117largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Brazil74 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07533175See eligibility →

Recruiting nowPhase 3

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Obesity, Weight GainCondition

Tirzepatide, PlaceboTreatment

Argentina, Australia69 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06439277See eligibility →

Recruiting nowPhase 3

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Obesity, OverweightCondition

Orforglipron, PlaceboTreatment

Belgium, Brazil117 locations

Eli Lilly and CompanySponsor

Updated 2026-08-24 · NCT06672549See eligibility →

Recruiting nowNot applicable

Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients

Obesity, Morbid, Extubation FailureCondition

Noninvasive ventilation alternating with high flow nasal cannula, High flow nasal cannulaTreatment

Mexico, United States5 locations

Rush University Medical CenterSponsor

Updated 2026-08-07 · NCT05918575See eligibility →

Recruiting nowPhase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver DiseaseCondition

Metabolic surgery, Incretin-Based TherapyTreatment

Brazil, Canada22 locations

The Cleveland ClinicSponsor

Updated 2026-07-31 · NCT06374875See eligibility →

Recruiting nowNot applicable

Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery

Obesity, Bariatric SurgeryCondition

Indocyanine Green AngiogramTreatment

Mexico1 locations

Instituto Mexicano del Seguro SocialSponsor

Updated 2026-03-27 · NCT07000539See eligibility →

Recruiting nowNot applicable

Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial

Overweight (BMI > 25)Condition

Pecan nut oil supplementationTreatment

Mexico1 locations

Universidad Autonoma de Nuevo LeonSponsor

Updated 2026-03-27 · NCT07497555See eligibility →

Recruiting nowNot applicable

Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children.

Overweight and/or Obesity, Children - MalnutritionCondition

School B, ControlTreatment

Mexico1 locations

Claudia Teresa Tovar PalacioSponsor

Updated 2026-03-24 · NCT07159971See eligibility →

Recruiting nowPhase 4

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Psoriasis (PsO), Obesity & OverweightCondition

Semaglutide (Rybelsus®), PlaceboTreatment

Mexico1 locations

Hospital Universitario Dr. Jose E. GonzalezSponsor

Updated 2026-02-11 · NCT07401992See eligibility →

Recruiting nowPhase 3

Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)

Acute Myocardial Infarction With ST ElevationCondition

Dapagliflozin 10 MG Oral Tablet, Semaglutide (Rybelsus®)Treatment

Mexico1 locations

Instituto Mexicano del Seguro SocialSponsor

Updated 2026-01-05 · NCT07295223See eligibility →

Recruiting nowPhase 3

Epicardial Cardiac Fat-CT (EPIC-CT)

STEMI - ST Elevation Myocardial Infarction, Epicardial FatCondition

Dapagliflozin 10 MG Oral Tablet, Semaglutide (Rybelsus®)Treatment

Mexico1 locations

Instituto Mexicano del Seguro SocialSponsor

Updated 2026-01-02 · NCT07297589See eligibility →

Recruiting nowPhase 4

Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.

Morbid Obesity Requiring Bariatric Surgery, Postoperative PainCondition

Intravenous Lidocaine infusion + Standard Anesthesia, Intravenous Dexmedetomidine infusion + Standard AnesthesiaTreatment

Mexico2 locations

Instituto Mexicano del Seguro SocialSponsor

Updated 2025-11-28 · NCT07073846See eligibility →

Recruiting nowNot applicable

Evaluation of Cognitive Improvement After Bariatric Surgery Using a Virtual Reality Program and the Neuropsi Neuropsychological Battery

Obesity (Disorder), Obesity and Obesity-related Medical ConditionsCondition

Bariatric SurgeryTreatment

Canada, Mexico2 locations

Hospital General de México Dr. Eduardo LiceagaSponsor

Updated 2025-11-17 · NCT07229924See eligibility →

Recruiting nowNot applicable

Multidimensional Intervention in Mexican Schoolchildren

Childhood Obesity, Pediatric ObesityCondition

Healthy and Sustainable Eating, Movement behaviorsTreatment

Mexico1 locations

Mexican National Institute of Public HealthSponsor

Updated 2025-09-22 · NCT07185789See eligibility →

Recruiting nowPhase 3

DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity

HIV - Human Immunodeficiency Virus, ObesityCondition

DOR/3TC/TDF, BIC/FTC/TAFTreatment

Mexico1 locations

José Antonio Mata MarínSponsor

Updated 2025-08-24 · NCT07075146See eligibility →

Recruiting nowNot applicable

Efficacy and Safety of Vitamin D Supplementation in Pediatric Patients with Obesity

Vitamin D, Insulin ResistanceCondition

CholecalciferolTreatment

Mexico1 locations

Coordinación de Investigación en Salud, MexicoSponsor

Updated 2025-03-24 · NCT06847373See eligibility →

Opening soonNot applicable

Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With Obesity

Obesity (BMI>30), NeuroinflammationCondition

Ascorbic acid (Vitamin C), tocopherol alphaTreatment

Mexico1 locations

Autonomous University of MorelosSponsor

Updated 2026-08-24 · NCT07782411See eligibility →

Opening soonPhase 3

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

Orforglipron, DulaglutideTreatment

Belgium, Brazil71 locations

Eli Lilly and CompanySponsor

Updated 2026-08-19 · NCT07668336See eligibility →

Opening soonPhase 3

BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)Condition

Bofanglutide, SemaglutideTreatment

Mexico7 locations

Carnot LaboratoriesSponsor

Updated 2026-06-05 · NCT07628985See eligibility →

Opening soonPhase 3

BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity

Obesity & OverweightCondition

Bofanglutida, SemaglutideTreatment

Mexico6 locations

Carnot LaboratoriesSponsor

Updated 2026-06-03 · NCT07622810See eligibility →

Opening soonPhase 3

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Argentina, Brazil56 locations

Novo Nordisk A/SSponsor

Updated 2026-05-28 · NCT07282613See eligibility →

Opening soonNot applicable

Effect of Oral Calcium Butyrate Supplementation in Obesity

ObesityCondition

Placebo, Calcium butyrateTreatment

Mexico1 locations

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSponsor

Updated 2026-05-13 · NCT07583017See eligibility →

Opening soonNot applicable

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Psoriatic Arthritis, OsteoarthitisCondition

TirzepatideTreatment

Mexico1 locations

JULIO GRANADOS MONTIELSponsor

Updated 2026-05-12 · NCT07567378See eligibility →

Opening soonNot applicable

Iron Metabolism in Obesity

Obesity (Disorder)Condition

Bariatric Sleeve SurgeryTreatment

Mexico1 locations

TecSalud Investigación ClínicaSponsor

Updated 2025-09-05 · NCT07157332See eligibility →

Opening soonNot applicable

INNUPREC (Nutrigenetic Intervention for the Prevention of Cardiovascular Disease)

Abdominal ObesityCondition

Nutrigenetic diet according the genetic test, Control intervention groupTreatment

Mexico1 locations

University of GuadalajaraSponsor

Updated 2025-03-03 · NCT06847243See eligibility →

Opening soonNot applicable

FatMax Training on Metabolic and Epigenetic Parameters

Overweight and Obesity, Body Weight ChangesCondition

FatMAx training intervention, FatMax and physical endurance exercise interventionTreatment

Mexico1 locations

Universidad Autonoma de Baja CaliforniaSponsor

Updated 2024-08-15 · NCT06553482See eligibility →

Opening soonNot applicable

Impact of a Playful Family Education Strategy With ICT on Childhood Obesity Prevention

Pediatric Obesity, Childhood ObesityCondition

Conventional treatment, Playful Family Education StrategyTreatment

Mexico1 locations

Instituto Mexicano del Seguro SocialSponsor

Updated 2024-07-03 · NCT06486493See eligibility →

Invitation onlyNot applicable

Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemical Biomarkers, and Perceived Exertion in Adults With Obesity

Obesity & OverweightCondition

Intervention, InterventionTreatment

Mexico1 locations

Centro Universitario de Tlajomulco, Universidad de GuadalajaraSponsor

Updated 2026-03-03 · NCT07444736See eligibility →

Invitation onlyNot applicable

Use of a Mobile Application by Parents to Prevent Obesity in Their Children Apply for Your Health

Obesity, OverweightCondition

Applícate por tu saludTreatment

Mexico1 locations

Hospital Infantil de Mexico Federico GomezSponsor

Updated 2026-02-05 · NCT07376252See eligibility →

Invitation onlyNot applicable

Effect of High-intensity Interval Training on Cardiometabolic Health and Physical Fitness in Young Adults With Obesity

Obesity & OverweightCondition

High-intensity interval training intervention, Moderate-intensity continuous training interventionTreatment

Mexico1 locations

Centro Universitario de Tlajomulco, Universidad de GuadalajaraSponsor

Updated 2025-12-15 · NCT07283406See eligibility →

Active, not recruitingPhase 3

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

ObesityCondition

Semaglutide, PlaceboTreatment

Austria, Belgium56 locations

Novo Nordisk A/SSponsor

Updated 2026-08-07 · NCT05726227See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Type 2 DiabetesCondition

Retatrutide, PlaceboTreatment

Argentina, Brazil76 locations

Eli Lilly and CompanySponsor

Updated 2026-07-20 · NCT06297603See eligibility →

Active, not recruitingPhase 3

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

ObesityCondition

Liraglutide, PlaceboTreatment

Belgium, India32 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT04775082See eligibility →

Active, not recruitingPhase 2

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Overweight or Obese, Type 2 Diabetes Mellitus (T2DM)Condition

Placebo, EnicepatideTreatment

Argentina, Canada70 locations

Carmot Therapeutics, Inc.Sponsor

Updated 2026-06-24 · NCT06628362See eligibility →

Active, not recruitingPhase 4

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

ObesityCondition

SemaglutideTreatment

Belgium, Canada93 locations

Novo Nordisk A/SSponsor

Updated 2026-06-02 · NCT06571383See eligibility →

Active, not recruitingNot applicable

Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and Obesity

Overweight and ObesityCondition

Capsipro supplementation, Corn starch placeboTreatment

Mexico1 locations

Universidad Autonoma de Baja CaliforniaSponsor

Updated 2026-05-22 · NCT07602361See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Diabetes Mellitus, Type 2Condition

Retatrutide, SemaglutideTreatment

Argentina, Canada77 locations

Eli Lilly and CompanySponsor

Updated 2026-04-13 · NCT06260722See eligibility →

Active, not recruitingPhase 2

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Type 2 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Mexico40 locations

Eli Lilly and CompanySponsor

Updated 2026-03-23 · NCT06037252See eligibility →

Active, not recruitingPhase 3

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

Type 1 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Brazil79 locations

Eli Lilly and CompanySponsor

Updated 2026-02-17 · NCT06962280See eligibility →

Active, not recruitingNot applicable

Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System in Mexico

Obesity, Type 2 DiabetesCondition

MAGNET System, DI BiofragmentableTreatment

Mexico1 locations

GT Metabolic Solutions, Inc.Sponsor

Updated 2025-12-23 · NCT07085741See eligibility →

Active, not recruitingPhase 4

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Type 2 DiabetesCondition

Tirzepatide, Antihyperglycemic medicationTreatment

Argentina, Canada90 locations

Eli Lilly and CompanySponsor

Updated 2025-12-12 · NCT05433584See eligibility →

Active, not recruitingNot applicable

Effects of Vitamin D Supplementation in Adolescents With Asthma, Obesity and Vitamin D Deficiency.

Non-allergic Asthma, ObesityCondition

Vitamin D₃ (25-hydroxy vitamin D), Vitamin D₃ (25-hydroxy vitamin D)Treatment

Mexico1 locations

Hospital Infantil de Mexico Federico GomezSponsor

Updated 2025-09-15 · NCT05431920See eligibility →

Active, not recruitingNot applicable

Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota

Obesity, Pre DiabetesCondition

A package containing a mix of functional foods, Placebo ingredient groupTreatment

Mexico2 locations

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSponsor

Updated 2025-04-24 · NCT05230342See eligibility →

Active, not recruitingNot applicable

Cognitive-Behavioral Intervention to Increase Tummy Time Practice and Maintain Healthy Weight in Infants

Obesity/therapy, Prevention and ControlCondition

Tummy Time for the prevention of childhood obesityTreatment

Mexico1 locations

Universidad Autonoma de Nuevo LeonSponsor

Updated 2025-02-20 · NCT06616467See eligibility →

Active, not recruitingNot applicable

Effect of a Food Supplement with Natural Extracts of Cocoa, Amaranth Seed and Ginger in Overweight or Obese Patients

Oxidative Stress, Inflammation BiomarkersCondition

Cocoa, amaranth seed and ginger, Amaranth seedTreatment

Mexico1 locations

University of GuadalajaraSponsor

Updated 2025-01-10 · NCT06769035See eligibility →

Related countries

United States1,107 China326 Canada158 France110 Spain98 Germany95

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.